We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$19.7B
1-Year Est. Return
39.39%
This Fund
S&P 500
This Quarter
Est. Return
+17.95%
1 Year Est. Return
+39.39%
3 Year Est. Return
+109.64%
5 Year Est. Return
+114.77%
10 Year Est. Return
+339.3%
AUM
$19.7B
AUM Growth
+$4.27B
(+28%)
Cap. Flow
+$1.78B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
24.77%
Holding
2,672
New
452
Increased
653
Reduced
572
Closed
618
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 2 |
SEM
Select Medical
SEM
|
+$198M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$193M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$95.9M |
| 5 |
CME Group
CME
|
+$88.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$70.9M |
| 2 |
CWAN
Clearwater Analytics
CWAN
|
+$67.5M |
| 3 |
Old National Bancorp
ONB
|
+$63M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$62.5M |
| 5 |
Cincinnati Financial
CINF
|
+$43.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.51% |
| 2 | Financials | 11.55% |
| 3 | Technology | 7.51% |
| 4 | Industrials | 6.91% |
| 5 | Consumer Discretionary | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APGE
1726
CALL
DELISTED
Apogee Therapeutics
APGE
| $265K | ﹤0.01% |
+2,000
| New | +$180K |
|
|
JBTM
1727
JBT Marel
JBTM
$5.71B
| $264K | ﹤0.01% |
1,824
-3,121
| -63% | -$404K |
|
1728
Goldman Sachs
GS
$274B
| $264K | ﹤0.01% |
261
-181
| -41% | -$176K |
|
|
TALK
1729
DELISTED
Talkspace
TALK
| $260K | ﹤0.01% |
50,000
| – | – |
|
|
CHMI
1730
Cherry Hill Mortgage Investment Corp
CHMI
$104M
| $260K | ﹤0.01% |
112,003
+70,851
| +172% | +$177K |
|
1731
PUT
Merck
MRK
$362B
| $257K | ﹤0.01% |
2,000
-800
| -29% | -$93.6K |
|
1732
CALL
Geron
GERN
$835M
| $256K | ﹤0.01% |
+200,000
| New | +$282K |
|
|
CGC
1733
PUT
Canopy Growth
CGC
$395M
| $255K | ﹤0.01% |
267,900
+21,000
| +9% | +$22.3K |
|
|
TDACW
1734
Translational Development Acquisition Corp Warrants
TDACW
| $253K | ﹤0.01% |
191,700
-256,295
| -57% | -$257K |
|
1735
PUT
Amdocs
DOX
$6.19B
| $253K | ﹤0.01% |
5,000
| – | – |
|
1736
Intuit
INTU
$81B
| $252K | ﹤0.01% |
965
-15,593
| -94% | -$5.43M |
|
1737
CALL
Thermo Fisher Scientific
TMO
$241B
| $251K | ﹤0.01% |
+500
| New | +$240K |
|
1738
PUT
PayPal
PYPL
$44.8B
| $250K | ﹤0.01% |
5,800
-100,900
| -95% | -$4.59M |
|
1739
CALL
Fastenal
FAST
$56.2B
| $250K | ﹤0.01% |
+5,200
| New | +$236K |
|
1740
PUT
Clorox
CLX
$10B
| $248K | ﹤0.01% |
2,600
| – | – |
|
1741
ImmunityBio
IBRX
$8.99B
| $248K | ﹤0.01% |
+28,280
| New | +$214K |
|
1742
ARS Pharmaceuticals
SPRY
$409M
| $246K | ﹤0.01% |
+30,750
| New | +$265K |
|
1743
PACCAR
PCAR
$61.1B
| $246K | ﹤0.01% |
2,044
-1,471
| -42% | -$174K |
|
|
TVAIR
1744
Thayer Ventures Acquisition Corporation II Rights
TVAIR
| $243K | ﹤0.01% |
1,280,188
| – | – |
|
1745
CALL
Backblaze
BLZE
$815M
| $243K | ﹤0.01% |
+15,300
| New | +$106K |
|
1746
PUT
Tractor Supply
TSCO
$16.8B
| $240K | ﹤0.01% |
7,600
| – | – |
|
1747
PENN Entertainment
PENN
$2.21B
| $240K | ﹤0.01% |
11,225
-489,146
| -98% | -$8.77M |
|
1748
ESAB
ESAB
$4.04B
| $238K | ﹤0.01% |
2,411
-26,574
| -92% | -$2.57M |
|
1749
CALL
GE Vernova
GEV
$250B
| $235K | ﹤0.01% |
+200
| New | +$204K |
|
|
HVIIR
1750
Hennessy Capital Investment Corp VII Rights
HVIIR
| $234K | ﹤0.01% |
600,985
-7,905
| -1% | -$2.82K |
|
Similar funds
SPIA
FWIA
ASRS
PSCM
BBA
CWP
UM
SFA
Verition Fund Management's Q2 2026 Portfolio in Review
As of Q2 2026, Verition Fund Management held 2,672 positions worth $19.7B, up 28% from $15.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Verition Fund Management deployed $1.78B of net new capital in Q2 2026, opening 452 new positions and adding to 653 existing holdings. Its largest new stake was Select Medical: 12,025,235 shares worth $199M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 44% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Old National Bancorp, an estimated $63M trimmed.
- Verition Fund Management's largest Q2 2026 buy was Select Medical: 12,025,235 shares worth $199M.
- Verition Fund Management added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $1.09B increase.
- Verition Fund Management's biggest Q2 2026 reduction was Old National Bancorp, cutting an estimated $63M.
- Verition Fund Management fully exited Brown & Brown in Q2 2026, selling an estimated $70.9M.
- Verition Fund Management's ten largest holdings make up 25% of its $19.7B portfolio in Q2 2026.
- Verition Fund Management opened 452 new positions and closed 618 in Q2 2026.
- Verition Fund Management's portfolio value rose 28% quarter-over-quarter to $19.7B.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.